4QD6 | pdb_00004qd6

ITK kinase domain in complex with inhibitor compound


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.45 Å
  • R-Value Free: 
    0.267 (Depositor), 0.264 (DCC) 
  • R-Value Work: 
    0.209 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 
    0.212 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4QD6

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).

Trani, G.Barker, J.J.Bromidge, S.M.Brookfield, F.A.Burch, J.D.Chen, Y.Eigenbrot, C.Heifetz, A.Ismaili, M.H.Johnson, A.Krulle, T.M.MacKinnon, C.H.Maghames, R.McEwan, P.A.Montalbetti, C.A.Ortwine, D.F.Perez-Fuertes, Y.Vaidya, D.G.Wang, X.Zarrin, A.A.Pei, Z.

(2014) Bioorg Med Chem Lett 24: 5818-5823

  • DOI: https://doi.org/10.1016/j.bmcl.2014.10.020
  • Primary Citation Related Structures: 
    4QD6

  • PubMed Abstract: 

    Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2.


  • Organizational Affiliation
    • Discovery Chemistry, Evotec UK Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, UK. Electronic address: Giancarlo.Trani@evotec.com.

Macromolecule Content 

  • Total Structure Weight: 61.41 kDa 
  • Atom Count: 3,988 
  • Modeled Residue Count: 487 
  • Deposited Residue Count: 532 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Tyrosine-protein kinase ITK/TSK
A, B
266Homo sapiensMutation(s): 1 
Gene Names: ITKEMTLYK
EC: 2.7.10.2
UniProt & NIH Common Fund Data Resources
Find proteins for Q08881 (Homo sapiens)
Explore Q08881 
Go to UniProtKB:  Q08881
PHAROS:  Q08881
GTEx:  ENSG00000113263 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ08881
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
30T

Query on 30T



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
trans-4-({6-[(5-phenyl-1H-pyrazol-3-yl)amino]-4-(phenylsulfonyl)pyridin-2-yl}amino)cyclohexanol
C26 H27 N5 O3 S
YIGXUZJWVOKKIO-MXVIHJGJSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.45 Å
  • R-Value Free:  0.267 (Depositor), 0.264 (DCC) 
  • R-Value Work:  0.209 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 0.212 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 40.06α = 90
b = 94.32β = 90
c = 156.34γ = 90
Software Package:
Software NamePurpose
GDAdata collection
PHASERphasing
REFMACrefinement
XDSdata reduction
XDSdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2015-01-14
    Type: Initial release
  • Version 1.1: 2024-02-28
    Changes: Data collection, Database references, Derived calculations